Icotrokinra met the primary endpoint of clinical response at all three doses, with 36.5% of patients treated achieving endoscopic improvement and 30.2% achieving clinical remission at the highest dose ...
People obviously have an interesting tastes in toys. The more squeamish side of the HuffPost Shopping team actually joked ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback